Results 61 to 70 of about 495,297 (403)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs

Frontiers in Veterinary Science, 2019
Glucocorticoid administration is a risk factor for thromboembolism in hypercoagulable dogs, and it is unknown if aspirin counteracts glucocorticoid-induced hypercoagulability. The objective was to determine the effects of sustained aspirin and prednisone
John M. Thomason, Allison P. Mooney, Joshua M. Price, Jacqueline C. Whittemore   +3 more
doaj   +1 more source

Effect of Aspirin on Disability‐free Survival in the Healthy Elderly

New England Journal of Medicine, 2018
BACKGROUND Information on the use of aspirin to increase healthy independent life span in older persons is limited. Whether 5 years of daily low‐dose aspirin therapy would extend disability‐free life in healthy seniors is unclear.
J. McNeil, R. Woods, M. Nelson, C. Reid, B. Kirpach, R. Wolfe, E. Storey, R. Shah, J. Lockery, A. Tonkin, A. Newman, J. Williamson, K. Margolis, M. Ernst, W. Abhayaratna, N. Stocks, S. Fitzgerald, S. Orchard, R. Trevaks, L. Beilin, G. Donnan, P. Gibbs, C. Johnston, J. Ryan, B. Radziszewska, R. Grimm, A. Murray   +26 more
semanticscholar   +1 more source

Contextualizing National Policies Regulating Access to Low‐Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Aspirin is widely administered to prevent cardiovascular disease (CVD). However, appropriate use of aspirin depends on patient understanding of its risks, benefits, and indications, especially where aspirin is available over the counter (OTC).
Alan P. Jacobsen, Zi Lun Lim, Blair Chang, Kaleb D. Lambeth, Thomas M. Das, Colin Gorry, Michael McCague, Faisal Sharif, Darren Mylotte, William Wijns, Patrick W. J .C. Serruys, Roger S. Blumenthal, Seth S. Martin, John W. McEvoy   +13 more
doaj   +1 more source

Adherence to secondary stroke prevention strategies - Results from the German stroke data bank [PDF]

, 2003
Only very limited data are available concerning patient adherence to antithrombotic medication intended to prevent a recurrent stroke. Reduced adherence and compliance could significantly influence the effects of any stroke prevention strategies.
Busse, O., Diener, H. C., Glahn, J., Hamann, Gerhard F., Weimar, C.   +4 more
core   +1 more source

Polypill with or without Aspirin in Persons without Cardiovascular Disease.

New England Journal of Medicine, 2020
BACKGROUND A polypill comprising statins, multiple blood-pressure-lowering drugs, and aspirin has been proposed to reduce the risk of cardiovascular disease.
S. Yusuf, P. Joseph, A. Dans, P. Gao, K. Teo, D. Xavier, P. López-Jaramillo, K. Yusoff, A. Santoso, H. Gamra, S. Talukder, Courtney Christou, P. Girish, K. Yeates, F. Xavier, G. Dagenais, Catalina Rocha, T. McCready, J. Tyrwhitt, J. Bosch, P. Pais   +20 more
semanticscholar   +1 more source

Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study. [PDF]

PLoS ONE, 2016
BACKGROUND:Low-dose aspirin is widely recommended for patients at high risk for cardiovascular disease (CVD); however, it remains uncertain whether long-term treatment adversely affects renal function in patients with diabetes.
Sadanori Okada, Takeshi Morimoto, Hisao Ogawa, Mio Sakuma, Hirofumi Soejima, Masafumi Nakayama, Hideaki Jinnouchi, Masako Waki, Yasuhiro Akai, Hitoshi Ishii, Yoshihiko Saito, Investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial   +11 more
doaj   +1 more source

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia

Journal of Clinical and Translational Science, 2023
OBJECTIVES/GOALS: Low-dose aspirin is an established treatment to prevent preeclampsia, a leading cause of maternal and perinatal complications. Nevertheless, aspirin failure is not uncommon.
Amihai Rottenstreich, Roger Vaughan, Barry S Coller   +2 more
doaj   +1 more source

Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! [PDF]

, 2017
No abstract ...
Aspirin Myocardial Infarction Study Research Group, Baigent, Baigent, Bonaca, Chin, Cleland, Cleland, Cleland, Cleland, Cleland, Cleland, Gelder, Homma, Lewis, Massie, Meune, Michel, Pitt, Pitt, Silva, Solomon, Tweeddale, Zannad, Zannad   +23 more
core   +1 more source

Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

JAMA Internal Medicine, 2020
Importance Patients undergoing total hip replacement (THR) and total knee replacement (TKR) receive venous thromboembolism (VTE) pharmacoprophylaxis. It is unclear which anticoagulant is preferable.
G. Matharu, S. Kunutsor, A. Judge, A. Blom, M. Whitehouse   +4 more
semanticscholar   +1 more source

Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational study. [PDF]

PLoS ONE, 2017
BACKGROUND:The association between preoperative aspirin use and postoperative acute kidney injury (AKI) in cardiovascular surgery is unclear. We sought to evaluate the effect of preoperative aspirin use on postoperative AKI in cardiac surgery.
Min Hur, Chang-Hoon Koo, Hyung-Chul Lee, Sun-Kyung Park, Minkyung Kim, Won Ho Kim, Jin-Tae Kim, Jae-Hyon Bahk   +7 more
doaj   +1 more source